<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Wed, 22 May 2013 06:28:23 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>Roche and Team Up to Launch Successful Startups in the Bay Area  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297004&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Roche and QB3 Team Up to Launch Successful Startups in the Bay Area &lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;Basel, Switzerland and Seattle, WA, USA  May 16, 2013 -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and the...</description><pubDate>Mon, 20 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Covidien plc Plans Mallinckrodt Inc. Spinoff for June 28  </title><link /><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DUBLIN--(BUSINESS WIRE)--Covidien (NYSE:COV) today announced 2013 full year guidance for Mallinckrodt plc as Mallinckrodt prepares to spin off from Covidien to become a separate, publicly traded company in mid...</description><pubDate>Mon, 06 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Amendia Inc. Invests $50 Million in Implant Spinoff  </title><link>http://www.bizjournals.com/atlanta/print-edition/2013/04/12/amendia-invests-50m-in-implant-spinoff.html</link><description>Specialty medical-device manufacturer Amendia Inc. will invest up to $50 million to commercialize a biomedical spinoff that focuses on implant technology and stem cell therapies. The new venture, Vivex Biomedical Inc., is developing implant technology to help stimulate bone regrowth. Vivex has also licensed a highly adaptive adult stem cell line, known as MIAMI (Marrow Isolated Adult Multi-lineage...</description><pubDate>Fri, 12 Apr 2013 12:00:00 AM GMT</pubDate></item><item><title>InDevR Spins Off  Raises Growth Capital  </title><link>http://www.biospace.com/news_story.aspx?StoryID=284811&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;DENVER, CO--(Marketwire - January   15, 2013) -   &lt;a href"http://www.virocyt.com/"&gt;ViroCyt, LLC&lt;/a&gt;, a privately-held life science company, announced today that it had begun operations after spinning off from InDevR, Inc. Concurrent with the formation of ViroCyt, funding was secured from a group of investors led by High Country Venture, a Colorado Venture Capital Fund. ViroCyt...</description><pubDate>Tue, 15 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>Oculus Innovative Sciences, Inc. Announces Plan to Spin Off Biotechnology Business  </title><link>http://www.biospace.com/news_story.aspx?StoryID=284470&amp;full=1</link><description>PETALUMA, Calif., Jan. 10, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that its board of directors has unanimously approved a spin-off of its novel biotechnology business, Ruthigen, Inc. &lt;br&gt;&lt;br&gt;Oculus management is currently working with securities counsel and bankers on a plan to provide equity in Ruthigen to Oculus shareholders. Oculus expects the...</description><pubDate>Thu, 10 Jan 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Cretex Companies&lt;/b&gt; Establishes &lt;b&gt;rms Surgical&lt;/b&gt; and Opens New Facility  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20121220005803&amp;newsLang=en</link><description>MINNEAPOLIS--(BUSINESS WIRE)--Under its recently formed Cretex Medical umbrella, Cretex announced that it has added rms Surgical. This new company represents a consolidation of rms Companys instrumentation manufacturing and JunoPacifics sterilization case and tray manufacturing.&lt;br&gt;&lt;br&gt;Its actually more of a reorganization effort to better serve our customers, remarked Dave Novak, President...</description><pubDate>Thu, 20 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>APEIRON Biologics AG Establishes Biotech-Spinoff  </title><link>http://www.biospace.com/news_story.aspx?StoryID=281280&amp;full=1</link><description>Vienna, 4 December 2012: APEIRON Biologics AG (Apeiron) today announced the launch of Attoquant Diagnostics GmbH (Attoquant) as a subsidiary. Attoquant will globally commercialize its already successfully marketed peptide analytics service RAS-FingerprintTM and further develop the underlying platform technology.&lt;/p&gt;&lt;p&gt;Vienna-based biotech company APEIRON Biologics AG (Apeiron) today announced the...</description><pubDate>Tue, 04 Dec 2012 12:00:00 AM GMT</pubDate></item><item><title>Covidien plc Updates on Pharma Spinout  </title><link>http://www.massdevice.com/news/covidien-updates-pharma-spinout</link><description>Covidien updates investors on the planned spinout of its pharmaceuticals business, expected by mid-2013. With strong fiscal 2012 numbers under its belt, Covidien (NYSE:COV) updated investors today on its expected financials after it spins out its pharmaceuticals business next year. The Mansfield, Mass.-based medical device company said late last year that it planned to ditch the no-or-low-growth pharma...</description><pubDate>Wed, 28 Nov 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Thogus&lt;/b&gt; Launches &lt;b&gt;JALEX&lt;/b&gt; Medical Device Company  </title><link>http://www.pddnet.com/news/2012/10/thogus-launches-jalex-medical-device-company</link><description>Thogus, a 62-year old custom injection molder, has expanded services to include rapidly developing medical device market. JALEX Medical will focus exclusively on biomedical engineering, product development and regulatory/quality assistance. JALEX joins Thogus and Rapid Prototyping and Manufacturing (rpm) under the same roof, fostering accelerated product design through complete production. Our clients...</description><pubDate>Wed, 24 Oct 2012 12:00:00 AM GMT</pubDate></item><item><title>Tyco International Ltd. Completes Separation Process  </title><link>http://www.biospace.com/news_story.aspx?StoryID=274513&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;SCHAFFHAUSEN, &lt;span class"xn-location"&gt;Switzerland&lt;/span&gt;, &lt;span class"xn-chron"&gt;Sept. 28, 2012&lt;/span&gt; /PRNewswire/ -- Today Tyco (NYSE: TYC), the world's largest dedicated fire protection and security company, completed its separation transaction. &lt;br /&gt;&lt;/p&gt;&lt;p&gt;Tyco is a $10 billion global leader in fire protection and security solutions. Tyco designs, manufactures, installs...</description><pubDate>Fri, 28 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Abbott Laboratories' Device, Dx Biz Poised for Growth After Spin-Out Finalizes; Analysts  </title><link>https://www.massdevice.com/news/analysts-differ-abbotts-post-split-prospects-wall-street-beat</link><description>Analysts on Wall Street are divided in their assessments of Abbott's prospects after it spins out its branded pharmaceuticals business. Wall Street analysts are by and large predicting good things for Abbott (NYSE:ABT) after it spins out its branded pharmaceuticals division, to be named AbbVie, early next year. But, although some are decidedly bullish on ABT, others are taking a more cautious approach...</description><pubDate>Fri, 21 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Tyco International Ltd. Announces Shareholder Approval of Spinoffs and Provides Fourth Quarter Update  </title><link>http://www.biospace.com/news_story.aspx?StoryID=273217&amp;full=1</link><description> &lt;div class"xn-content"&gt;&lt;p&gt;SCHAFFHAUSEN, &lt;span class"xn-location"&gt;Switzerland&lt;/span&gt;, &lt;span class"xn-chron"&gt;Sept. 17, 2012&lt;/span&gt; /PRNewswire/ -- Tyco International Ltd. (NYSE: TYC) today announced that its shareholders have approved the spinoffs of its North American ADT business and its flow control business. As a result, the Company expects to complete the distributions of equity interests in...</description><pubDate>Mon, 17 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Beacon Endoscopic Announces Spin-Off Business for Incisionless Digestive Bypass Technology  </title><link>http://www.biospace.com/news_story.aspx?StoryID=272843&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;NEWTON, MA--(Marketwire - September 13, 2012) -   Beacon Endoscopic Corporation, an emerging GI endoscopy company, announced today a spin-off business, GI Windows, that will develop and bring to market a technology involving a series of self-assembling magnets (SAMSEN) for incisionless bypass procedures within the digestive system. &lt;p&gt;Two years ago, professors and physicians...</description><pubDate>Thu, 13 Sep 2012 12:00:00 AM GMT</pubDate></item><item><title>Queen???s Spin-out Company,  in Bid to Revolutionize Cancer Diagnosis  </title><link>http://www.scientistlive.com/European-Food-Scientist/imaging_microscopy/New_spin-in_company_to_revolutionise_cancer_detection____/25667/</link><description>Queens University has teamed up with a medical imaging company in a venture that has the potential to revolutionise cancer detection and treatment. The universitys spin-out company QUBIS has taken an equity shareholding in Cirdan Imaging, which develops imaging equipment to assist clinicians in the detection, diagnosis and treatment of cancer. The new devices will be used in diagnostic procedures...</description><pubDate>Mon, 16 Jul 2012 12:00:00 AM GMT</pubDate></item><item><title>Biomet Inc. Considers Spinning out Dental Biz  </title><link>https://www.massdevice.com/news/biomet-considers-spinning-out-dental-wall-street-beat</link><description>Biomet decides to explore options for spinning out its 3i dental devices division, following Abbott's lead and Goldman Sachs' advice to another device maker.  In a growing trend among device makers, Biomet Inc. announced that it's exploring strategic options to spin out its 3i dental devices division. The company is just testing the waters and a split isn't guaranteed, but if completed the move will...</description><pubDate>Tue, 05 Jun 2012 12:00:00 AM GMT</pubDate></item><item><title>Dixtal Medical, Inc. Launches New Biomedical Company  </title><link /><description>Brentwood, TN (PRWEB) May 23, 2012 -- Second Life Biomedical was started as a subsidiary company of Dixie Medical in early 2012. For over 13 years, Dixie Medical has provided defibrillators and other medical equipment to over 20,000 customers in the U.S. and abroad. Originally started to service Dixies current defibrillator customer base, Second Life Biomedical has quickly expanded into servicing...</description><pubDate>Fri, 25 May 2012 12:00:00 AM GMT</pubDate></item><item><title>Biomagnetics Diagnostics Corporation Details Spin Off of  </title><link /><description>SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the Company has received a commitment for financing to advance the companies growth programs.&lt;/p&gt;&lt;p&gt;The company has taken an equity position of...</description><pubDate>Mon, 19 Mar 2012 12:00:00 AM GMT</pubDate></item><item><title>Vitrolife Preparing Distribution of the Transplantation Business  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20120319005624&amp;newsLang=en</link><description>GTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:&lt;br&gt;&lt;br&gt;Vitrolife AB (publ)(STO:VITR) is today publishing the decision of the Board to begin preparations for a spin-off of the transplantation business, which today is run in the subsidiary Xvivo Perfusion AB. The spin-off will take place through distribution of the shares in the subsidiary in accordance with Lex Asea. It is intended that the...</description><pubDate>Mon, 19 Mar 2012 12:00:00 AM GMT</pubDate></item><item><title>Quintiles, Inc. Takes Stake in UK Biomarker Startup  </title><link>http://www.outsourcing-pharma.com/Commercial-Services/Quintiles-invests-3m-in-biomarker-R-D-firm-establishes-BPO-centre-in-China</link><description>Professors David Kerr and Nick La Thangue offer oncology consulting and biomarker R&amp;D activities spun out from the University of Oxford&lt;br&gt;&lt;br&gt;OXFORD, U.K. &amp; RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Continuing its commitment to advancing personalized medicine by offering world-leading experts and cutting-edge tools, Quintiles today announced that it has invested in a new company formed to...</description><pubDate>Wed, 18 Jan 2012 12:00:00 AM GMT</pubDate></item><item><title>Roswell Park Cancer Institute, University at Buffalo Spinoff Takes Simulator to Sweden  </title><link>http://www.bizjournals.com/buffalo/news/2012/01/17/rpci-ub-spinoff-takes-simulator-to.html?ana=otjrss</link><description>Business First by Tracey Drury, Buffalo Business First Reporter &lt;/p&gt;&lt;p&gt;A Buffalo biotechnology company has begun selling its product internationally, completing a sale in Stockholm, Sweden.&lt;/p&gt;&lt;p&gt;Simulated Surgical Systems LLC, a spin-off from Roswell Park Cancer Institute and the University at Buffalo, this month delivered its Robotic Surgery Simulator (RoSS) to the Karolinska University Hospital...</description><pubDate>Wed, 18 Jan 2012 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Austen BioInnovation Institute&lt;/b&gt; Spins Off Orthopedic Device Company, &lt;b&gt;APTO Orthopaedics&lt;/b&gt;  </title><link>http://www.qmed.com/news/austen-bioinnovation-institute-spins-orthopedic-device-company</link><description>AKRON, Ohio, Jan. 12, 2012 /PRNewswire via COMTEX/ -- Culture of innovation accelerates development of non-invasive device to treat spinal deformities in children &lt;/p&gt;&lt;p&gt;Austen BioInnovation Institute in Akron (ABIA) announced today the formation of APTO Orthopaedics, the first medical device company created out of the Institute. ABIA's Dr. Steve Fening and Akron Children's Hospital's Dr. Todd...</description><pubDate>Mon, 16 Jan 2012 12:00:00 AM GMT</pubDate></item><item><title>Ion Beam Applications (IBA) to Net Over 100 Million Euro After Unit Stake Sale, New Molecular-Imaging Company Created  </title><link>http://www.reuters.com/article/2012/01/09/ionbeamapplications-brief-idUSL6E8C90X020120109</link><description>Louvain-La-Neuve, Belgium,  Jan. 9, 2012  IBA (Ion Beam Applications S.A.) and SK Capital Partners, a U.S. based private investment firm, announce that they have entered into an agreement to create IBA Molecular Imaging, a jointly-owned new company derived from IBAs molecular imaging division. SK Capital Partners will own 60% of the new company while IBA will have a 40% stake. The parties...</description><pubDate>Tue, 10 Jan 2012 12:00:00 AM GMT</pubDate></item><item><title>Smith &amp; Nephew Inc. Spins Off Biologics Unit Into JV With Essex Woodlands Health Ventures  </title><link>http://www.thisislondon.co.uk/standard-business/article-24025155-smith-and-nephew-in-therapy-joint-venture.do</link><description>HOUSTON, TX--(Marketwire -01/04/12)- Essex Woodlands (www.ewhv.com), a global healthcare growth equity and venture capital firm, announced today a strategic partnership with Smith &amp; Nephew (http://global.smith-nephew.com/master/6600.html), the largest UK-based medical device company, to fund the spinout of Smith &amp; Nephew's Biologics and Clinical Therapies division and develop a leading global orthopedic...</description><pubDate>Wed, 04 Jan 2012 12:00:00 AM GMT</pubDate></item><item><title>Provectus Pharmaceuticals Inc. and its Subsidiaries Complete Unregistered Offering of Units to Facilitate Spin-off of  </title><link /><description>KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced today that it and its five wholly owned subsidiaries, Pure-ific Corporation, Provectus Biotech, Inc., Provectus Devicetech, Inc., Provectus Imaging, Inc., and Xantech Pharmaceuticals, Inc. (the Subsidiaries), have...</description><pubDate>Tue, 20 Dec 2011 12:00:00 AM GMT</pubDate></item><item><title>China Sky One Medical, Inc. Partners Up to Form New Stem Cell Company,  $36.3 Million Operation  </title><link>http://www.chinabiotoday.com/articles/20111216</link><description>December 16, 2011 -- China Sky One Medical, together with three partners, will invest $36.3 million to create a stem cell company, which will be called Harbin Tian Xin Biological Engineering. Besides providing umbilical cord cell banking, the new company will perform the clinical applications of bone marrow stem cells, intercord mesenchymal stem cells and other human stem cells. More details.......</description><pubDate>Fri, 16 Dec 2011 12:00:00 AM GMT</pubDate></item><item><title>Covidien plc Plans Spin-off of Pharmaceuticals Business  </title><link>http://www.rttnews.com/1782109/covidien-to-spin-off-pharmaceuticals-business-update.aspx?type=bn</link><description>DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV), a leading global provider of healthcare products, today announced that it plans to spin off its pharmaceuticals business into a standalone public company. &lt;/p&gt;&lt;p&gt;Covidiens pharmaceuticals business is one of the worlds largest producers of bulk acetaminophen, the largest United States supplier of opioid pain medications and is among the top ...</description><pubDate>Thu, 15 Dec 2011 12:00:00 AM GMT</pubDate></item><item><title>Arrayit Corporation to Spin-Off Arrayit Diagnostics to Shareholders  </title><link /><description>SUNNYVALE, Calif.--(BUSINESS WIRE)--Arrayit Corporation (OTCBB: ARYC - News) has approved the spin-off of its majority owned subsidiary, Arrayit Diagnostics, Inc. Arrayit Corporation will distribute to its existing shareholders its 78.18% interest in Arrayit Diagnostics as a stock dividend. The stock dividend distribution date and further details are expected to be announced early in the first quarter...</description><pubDate>Wed, 14 Dec 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Qualcomm&lt;/b&gt; Launches Medical Devices Subsidiary, $100 Million Fund  </title><link>http://www.socaltech.com/qualcomm_launches_medical_devices_subsidiary_____m_fund/s-0039729.html</link><description>SAN DIEGO, Dec. 5, 2011 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) announced today the formation of a wholly owned subsidiary, Qualcomm Life Inc., which will operate the business formerly known as Qualcomm Wireless Health, as well as the establishment of a $100 million Qualcomm Life Fund, an investment allocation established by Qualcomm Incorporated and to be managed by Qualcomm Ventures...</description><pubDate>Mon, 05 Dec 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Therix Medical&lt;/b&gt; Spins Out &lt;b&gt;Bluegrass Vascular Technologies&lt;/b&gt;, Developer of the Surfacer??? Inside-Out Access Catheter System  </title><link /><description>..LEXINGTON, Ky.--(BUSINESS WIRE)-- Medical technology incubator Therix Medical has announced the launch of spin-out Bluegrass Vascular Technologies, a stand-alone company dedicated to developing and commercializing life-saving devices and methods that address shortcomings in vascular access procedures. Bluegrass Vascular Technologies flagship product is the Surfacer Inside-Out Access Catheter System...</description><pubDate>Tue, 15 Nov 2011 12:00:00 AM GMT</pubDate></item><item><title>Allied Minds Spins Off Medical Device Subsidiary  </title><link>http://www.masshightech.com/stories/2011/11/07/daily23-Allied-Minds-forms-medical-devices-subsidiary.html</link><description>BOSTON--(BUSINESS WIRE)--Allied Minds, Inc. today announced the creation of Allied Minds Devices, LLC, a new subsidiary with a unique focus on developing medical devices originating from U.S. universities and federally funded research institutions. &lt;/p&gt;&lt;p&gt;Allied Minds Chief Executive Officer, Chris Silva, stated, Each year we review an incredible number of promising early-stage medtech innovations...</description><pubDate>Thu, 10 Nov 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Indo-US MIM Tec&lt;/b&gt; Announces Plan to Form New Medical Device Contract Manufacturing Firm, &lt;b&gt;Indo-Med&lt;/b&gt;  </title><link>http://www.biospace.com/news_story.aspx?StoryID=239669&amp;full=1</link><description>San Francisco  Nov. 7  Global precision components producer Indo-US MIM Tec (Bangalore, India and Princeton, N.J.), announced today that its board of directors has unanimously approved a plan to separate its medical device contract manufacturing services from the company in a transaction that will result in an independent and highly focused company, Indo-Med.&lt;/p&gt;&lt;p&gt;John Gaspervich, past president...</description><pubDate>Tue, 08 Nov 2011 12:00:00 AM GMT</pubDate></item><item><title>Kinetic Concepts, Inc. Gives Notice of Make-Whole Fundamental Change to Holders of Its 3.25% Convertible Senior Notes Due 2015  </title><link>http://www.businesswire.com/portal/site/biospace2/template.PAGE/menuitem.ce58e8202d51f40bfcb16f10c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20111104006056&amp;newsLang=en</link><description>SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. (NYSE: KCI) today provided notice to holders of its 3.25 percent Convertible Senior Notes due 2015 (the Notes) in respect of the merger (the Merger) of Chiron Merger Sub, Inc., a Texas corporation (Chiron Merger Sub) and a wholly owned subsidiary of Chiron Holdings, Inc., a Delaware corporation (Chiron), with and into Kinetic Concepts, Inc...</description><pubDate>Mon, 07 Nov 2011 12:00:00 AM GMT</pubDate></item><item><title>Medtronic, Inc. CEO Decides Against Spine Division Spinoff  </title><link>http://www.reuters.com/article/2011/10/28/us-medtronic-idUSTRE79R5NH20111028</link><description>St. Paul Business Journal by Mark Reilly, Managing Editor &lt;/p&gt;&lt;p&gt;Medtronic Inc.    .Medtronic Inc. Latest from The Business Journals Medtronic introduces new spinal fusion productMedtronic debuts new spinal fusion procedureThe case of the shrinking stent Follow this company .plans to hold onto its spine business, despite its troubles, and keeps all of its other businesses as well  except one...</description><pubDate>Thu, 03 Nov 2011 12:00:00 AM GMT</pubDate></item><item><title>Arsenal Medical Spins Out  </title><link>http://www.biospace.com/news_story.aspx?StoryID=237869&amp;full=1</link><description>WATERTOWN, Mass.--(BUSINESS WIRE)--Arsenal Medical, a privately-held company developing novel biomaterial-based local therapies, announced today that it has spun out 480 Biomedical, Inc. as a stand-alone company focused on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). &lt;/p&gt;&lt;p&gt;Concurrently, both Arsenal Medical and 480 Biomedical...</description><pubDate>Wed, 26 Oct 2011 12:00:00 AM GMT</pubDate></item><item><title>Abbott Laboratories to Split Into 2 Companies  </title><link>http://www.reuters.com/article/2011/10/19/abbott-idUSN1E79I06020111019</link><description>ABBOTT PARK, Ill., &lt;span class"xn-chron"&gt;Oct. 19, 2011&lt;/span&gt; /PRNewswire/ -- Today Abbott (NYSE: ABT) announced that it plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.  The diversified medical products company will consist of Abbott's existing diversified medical products portfolio, including its branded generic...</description><pubDate>Fri, 21 Oct 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Limestone&lt;/b&gt; Partners &lt;b&gt;Tristar&lt;/b&gt; to Form New Molecular Diagnostics Company, &lt;b&gt;Diagnovus&lt;/b&gt;  </title><link>http://www.biospace.com/news_story.aspx?StoryID=235245&amp;full=1</link><description>NASHVILLE, Tenn.&lt;/span&gt;, &lt;span class"xn-chron"&gt;Sept. 30, 2011&lt;/span&gt; /PRNewswire/ --&lt;b&gt;&lt;/b&gt;Limestone Fund and TriStar Technology Ventures are pleased to have joined together to form a new company, Diagnovus, LLC, which is headquartered in &lt;span class"xn-location"&gt;Nashville, Tennessee&lt;/span&gt;. As part of its creation, TriStar and Limestone also completed a seed financing round for the company.&lt;/p...</description><pubDate>Mon, 03 Oct 2011 12:00:00 AM GMT</pubDate></item><item><title>Case Western Reserve University Spinoff Looks to Commercialize "Cryo-Imaging" Technology  </title><link>http://www.medcitynews.com/2011/09/case-spinoff-bioinvision-looks-to-commercialize-cryo-imaging-technology/?edition=medical-devices</link><description>A Case Western Reserve University spinoff is planning to commercialize its high-resolution imaging technology that allows preclinical researchers to see the exact location of single cells and displays the information in a three-dimensional reconstruction of a mouse. Mayfield Village, Ohio-based BioInVision is kicking off the formal marketing launch of its cryo-imaging service at the World Molecular...</description><pubDate>Tue, 06 Sep 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;CERMA&lt;/b&gt; Creates Spin-Off Company &lt;b&gt;CERMAVEIN&lt;/b&gt; to Commercialise Steam Vein Sclerosis (SVS???) Technology in Varicose Vein Market  </title><link>http://www.biospace.com/news_story.aspx?StoryID=231539&amp;full=1</link><description>ARCHAMPS, France--(BUSINESS WIRE)-- French emerging medical technology company CERMA, specialized in the development of innovative and minimally invasive devices in phlebology and oncology, announced today the creation of spin-off CERMAVEIN. CERMAVEIN was launched to expand commercialization of its proprietary Steam Vein Sclerosis (SVS) technology for endovenous thermal ablation. SVS is the only product...</description><pubDate>Tue, 30 Aug 2011 12:00:00 AM GMT</pubDate></item><item><title>King's College London's Spins Out Medical Device Company  </title><link>http://www.electronicsweekly.com/blogs/uk-technology-startups/2011/07/kings-spins-out-medical-device.html</link><description>A spin-out company from King's College London has developed new technology to measure central blood pressure - a more accurate test of the health of your heart. Centron Diagnostics uses patent-pending technology developed by Professor Phil Chowienczyk's research group at King's cardiovascular division for its central blood pressure monitor. This is put on the patient in the same way as an arm blood...</description><pubDate>Thu, 21 Jul 2011 12:00:00 AM GMT</pubDate></item><item><title>Biocontrol Spins Off Epilepsy Treatment Unit; Will Keep its Heart Attack Treatment Business  </title><link>http://www.globes.co.il/serveen/globes/docview.asp?did=1000654079&amp;fid=1725</link><description>Medical devices company BioControl Medical Ltd. will spin off its epilepsy treatment business into a new company, Cerebral RX Ltd. BioControl will keep its heart attack treatment business. </description><pubDate>Tue, 14 Jun 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;PureTech Ventures&lt;/b&gt; Launches &lt;b&gt;Tal Medical&lt;/b&gt; to Develop Magnetic-Field Treatment for Depression  </title><link>http://www.xconomy.com/boston/2011/06/13/puretech-ventures-launches-tal-medical-to-develop-magnetic-field-treatment-for-depression/</link><description>Today a company called Tal Medical is starting up in Boston with the goal of developing an entirely new approach to treating depression, inspired by a specific type of magnetic field found in some MRI imaging machines. The research is still very early, but the treatmentdeveloped at McClean Hospital in Belmont, MAwas promising enough to win backing from Boston-based PureTech Ventures and to attract...</description><pubDate>Tue, 14 Jun 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;ImageIQ Inc.&lt;/b&gt;, Becomes &lt;b&gt;Cleveland Clinic Innovations&lt;/b&gt; Spin-off CRO Company for Research, Medical Device and Pharmaceutical Image Acquisition, Visualization and Analysis  </title><link>http://www.biospace.com/news_story.aspx?StoryID=221376&amp;full=1</link><description>CLEVELAND--(BUSINESS WIRE)--ImageIQ, an imaging contract research organization (CRO) specializing in advanced medical image acquisition, analysis and visualization, today announced the companys spin-out of technology and expertise developed at Cleveland Clinic Innovations. Concurrent with the formation of the company, Cleveland Clinic Innovations announces the appointment of Timothy Kulbago as President...</description><pubDate>Thu, 19 May 2011 12:00:00 AM GMT</pubDate></item><item><title>Biomagnetics Diagnostics Corporation Provides Investor Update on Spin Off of Low Carbon Diesel Project ??? Moves into Financing Due Diligence Phase  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20110405006114&amp;newsLang=en</link><description>SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced the Companys status on its proposed spin off of its low carbon diesel project. Last week, CEO, Clayton Hardman, travelled to China...</description><pubDate>Tue, 05 Apr 2011 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Bioxydyn&lt;/b&gt; Sets its Sights on Tackling COPD  </title><link>http://www.biospace.com/news_story.aspx?StoryID=213594&amp;full=1</link><description>MANCHESTER, England, March 10, 2011 /PRNewswire/ -- A unique, non-invasive magnetic imaging (MRI) tool is being developed by The University of Manchester (http://www.manchester.ac.uk/) spinout company Bioxydyn (http://www.bioxydyn.com/). It has the potential to considerably improve the treatment of lung conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis and emphasema...</description><pubDate>Fri, 11 Mar 2011 12:00:00 AM GMT</pubDate></item><item><title>Medtronic, Inc. to Spin Off Physio-Control  </title><link>http://www.xconomy.com/seattle/2011/02/22/medtronic-to-spin-off-physio/</link><description>Xconomy - Minneapolis, MN-based Medtronic (NYSE: MDT), the medical device giant, said today it is reviving plans to spin off the Physio-Control unit in Redmond, WA as an independent company. Physio-Control, which makes heart defibrillators that treat sudden cardiac arrest, has been dogged by manufacturing problems for years, although it was given clearance by the FDA to resume unrestricted sales last...</description><pubDate>Thu, 24 Feb 2011 12:00:00 AM GMT</pubDate></item><item><title>BIOLASE Technology, Inc. Announces the Formation of a New Division:  </title><link>http://www.biospace.com/news_story.aspx?StoryID=211791&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;IRVINE, CA--(Marketwire - February  24, 2011) -    BIOLASE Technology, Inc. (NASDAQ: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerBLTI"&gt;BLTI&lt;/a&gt;), the World's leading dental laser manufacturer and distributor, today announced that it has formed a new division, BIOLASE Imaging, to design and distribute state-of-the-art extra-oral and intra-oral dental imaging devices...</description><pubDate>Thu, 24 Feb 2011 12:00:00 AM GMT</pubDate></item><item><title>HepaLife Technologies Inc. Launches to Capitalize on New Market Opportunities  </title><link /><description>NEW YORK--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (HepaLife), an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, today announces the formation of a new wholly owned subsidiary, Alliqua BioMedical, Inc. (Alliqua).Alliqua intends to develop, manufacture and market its own proprietary...</description><pubDate>Mon, 01 Nov 2010 12:00:00 AM GMT</pubDate></item><item><title>University of Minnesota Spins Off Med-Tech Startup  </title><link>http://www.startribune.com/business/104823914.html?elr=KArks:DCiU1OiP:DiiUiD3aPc:_Yyc:aUoD3aPc:_2yc:a_ncyD_MDCiU</link><description>Minneapolis / St. Paul Business Journal - by Katharine Grayson Staff Writer -- The University of Minnesota has spun off a startup company that will develop a medical device for treating a chronic vein condition.&lt;p&gt;&lt;/p&gt;The technology is aimed at helping patients who suffer from chronic venous insufficiency, or CVI. The disease causes blood to pool in leg veins, and can lead to ulcers and infections...</description><pubDate>Thu, 14 Oct 2010 12:00:00 AM GMT</pubDate></item><item><title>Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company Intimate Bridge to Conception, Inc.  </title><link>http://www.biospace.com/news_story.aspx?StoryID=194983&amp;full=1</link><description>&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;PITTSBURGH&lt;/span&gt;, &lt;span class"xn-chron"&gt;Sept. 21&lt;/span&gt; /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to western &lt;span class"xn-location"&gt;Pennsylvania&lt;/span&gt;'s life sciences enterprises, announced today that one of its...</description><pubDate>Wed, 22 Sep 2010 12:00:00 AM GMT</pubDate></item><item><title>Analogic Corporation''s Launches New Company With $5 Million Investment  </title><link>http://www.xconomy.com/boston/2010/08/24/5m-for-photo-diagnostic-systems/</link><description>BizJournals -- Bernard Gordon, founder and former CEO of Analogic Corp. and co-founder of NeuroLogica Corp., has started another company in Danvers-based Photo Diagnostic Systems Inc. Like NeuroLogica, which shares its space with Photo Diagnostics, the new company is focused on a niche area of medical imaging.</description><pubDate>Wed, 25 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>Konica Minolta Medical &amp; Graphic, Inc. Announces the Establishment of a Healthcare Products Sales Company in India  </title><link /><description>TOKYO--(BUSINESS WIRE)--Konica Minolta Medical &amp; Graphic, Inc. (Konica Minolta) today announced that it has established Konica Minolta Healthcare India Private Limited  a new sales and customer service company in Mumbai for expanding its healthcare products in Indian market.&lt;p&gt;&lt;/p&gt;In the healthcare field, where digital devices are rapidly increasing, Konica Minolta is providing diagnostic imaging...</description><pubDate>Tue, 10 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>PhotoCure Establishes US Subsidiary to Build Specialty Dermatology Business  </title><link>http://www.qmed.com/news/22474/photocure-establishes-us-subsidiary-build-specialty-dermatology-business</link><description>QMED -- Photocure, a Norwegian pharmaceutical company specialising in dermatology and cancer, today announce the establishment of its US subsidiary, Photocure Inc, and the appointment of Terry Conrad as President to build its specialty dermatology business in the US.</description><pubDate>Wed, 04 Aug 2010 12:00:00 AM GMT</pubDate></item><item><title>New Medical Device Company Evolves From The University of Michigan Medical Innovation Center  </title><link>http://www.biospace.com/news_story.aspx?StoryID=185400&amp;full=1</link><description> ANN ARBOR, Mich. - While observing surgeries and intensive care procedures, University of Michigan Medical Innovation Center fellows Adrienne Harris, Elyse Kemmerer, Merrell Sami and Steven White noticed that the current design for peripheral intravenous systems, or IVs, caused a great deal of hassle and had a high complication rate.&lt;p&gt;&lt;/p&gt;The experience inspired the fellows to start Tangent Medical...</description><pubDate>Fri, 25 Jun 2010 12:00:00 AM GMT</pubDate></item><item><title>Brain Tunnelgenix Technologies Launched To Harness Discovery of Brain Temperature Tunnel(TM); Company Has Raised More Than $4 Million in Funding  </title><link /><description>HAMDEN, Conn.--(BUSINESS WIRE)--Based on the groundbreaking discovery by Yale researcher Dr. Marc Abreu of the Brain Temperature Tunnel (BTT), Brain Tunnelgenix Technologies Corp. (BTT Corp.) has developed revolutionary technology that promises to transform human temperature measurement. Offering the key advancement in modern thermometry in 300 years -- the first noninvasive monitoring methodology...</description><pubDate>Tue, 22 Jun 2010 12:00:00 AM GMT</pubDate></item><item><title>BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop Treatments for Orthopedic Conditions Using Stem Cell Technology  </title><link /><description>ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTIM) announced today that it has organized a new subsidiary, OrthoCyte Corporation, for the purpose of developing novel therapeutics based on stem cell technology for the treatment of injuries and disorders affecting the musculoskeletal system, including therapeutics that would regenerate bone, cartilage, tendons and ligaments. BioTime will...</description><pubDate>Fri, 11 Jun 2010 12:00:00 AM GMT</pubDate></item><item><title>Devicor Medical Products to Buy Segment of Ethicon Endo-Surgery, Inc.; Spin-off to Choose Cincinnati Location for HQ  </title><link>http://www.bizjournals.com/cincinnati/stories/2010/05/31/story1.html</link><description>Business Courier -- Cincinnati stands to gain a new corporate headquarters that could rank among the regions largest private companies, thanks to the planned sale of the breast care business of Ethicon Endo-Surgery Inc.</description><pubDate>Fri, 28 May 2010 12:00:00 AM GMT</pubDate></item><item><title>Elan Corporation PLC Mulls Spinning Off Drug Delivery Unit to Create Two Publicly Listed Companies  </title><link>http://www.reuters.com/article/idCNLDE63I06D20100419?rpc=44</link><description>DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc has decided to explore the possibility of a separation of its Elan Drug Technologies (EDT) business. If executed, any transaction would create two distinct publicly listed companies: Elan BioNeurology and EDT, with each entity being a leader in its field of expertise. The purpose of this exploration is to accurately assess the opportunity and impact on...</description><pubDate>Mon, 19 Apr 2010 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;RCT&lt;/b&gt; and Zassi Medical Evolutions Form Leto Medical, LLC  </title><link>http://www.biospace.com/news_story.aspx?StoryID=168192&amp;full=1</link><description>&lt;!-- AddThis Button BEGIN --&gt;&lt;script type"text/javascript"&gt;var addthis_pub"bdwyer";&lt;/script&gt;&lt;a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"&gt;&lt;img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...</description><pubDate>Tue, 19 Jan 2010 12:00:00 AM GMT</pubDate></item><item><title>Zassi Medical Evolutions Spins out Electrical Stimulation Technology for Gastrointestinal Continence Control and Forms New Company with Technology Investment Firm  </title><link>http://www.biospace.com/news_story.aspx?StoryID=167676&amp;full=1</link><description>&lt;!-- AddThis Button BEGIN --&gt;&lt;script type"text/javascript"&gt;var addthis_pub"bdwyer";&lt;/script&gt;&lt;a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"&gt;&lt;img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border:0...</description><pubDate>Wed, 13 Jan 2010 12:00:00 AM GMT</pubDate></item><item><title>Cardinal Health, Inc. Will Spin Off its Medical Device Division  </title><link>http://www.forbes.com/feeds/ap/2009/08/31/business-health-care-us-cardinal-health-spinoff_6831330.html</link><description>  &lt;!-- AddThis Button BEGIN --&gt;&lt;script type"text/javascript"&gt;var addthis_pub"bdwyer";&lt;/script&gt;&lt;a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"&gt;&lt;img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...</description><pubDate>Tue, 01 Sep 2009 12:00:00 AM GMT</pubDate></item><item><title>Cardinal Health, Inc. Board Approves CareFusion Corporation Spinoff  </title><link>http://www.reuters.com/article/marketsNews/idINN1022167120090710?rpc=44</link><description>  &lt;!-- AddThis Button BEGIN --&gt;&lt;script type"text/javascript"&gt;var addthis_pub"bdwyer";&lt;/script&gt;&lt;a href"http://www.addthis.com/bookmark.php?v20" onmouseover"return addthis_open(this, '', '[URL]', '[TITLE]')" onmouseout"addthis_close()" onclick"return addthis_sendto()"&gt;&lt;img src"http://s7.addthis.com/static/btn/sm-share-en.gif" width"83" height"16" alt"Bookmark and Share" style"border...</description><pubDate>Tue, 14 Jul 2009 12:00:00 AM GMT</pubDate></item><item><title>Bio-Matrix Scientific Group Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc.  </title><link>http://www.biospace.com/news_story.aspx?StoryID=135905&amp;full=1</link><description>&lt;p&gt;SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. , a San Diego-based biotechnology research and development company, announced today that its Board of Directors has declared a stock dividend to common and preferred shareholders of record as of May 5th, 2009 to be paid to shareholders on or about May 15th, 2009.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Eligible registered Common shareholders will...</description><pubDate>Tue, 21 Apr 2009 12:00:00 AM GMT</pubDate></item><item><title>Cardinal Health, Inc. to Spin Off Medical Products Unit as CareFusion Corporation; Will Reduce Workforce by 1300 to Respond to Economic Conditions  </title><link>http://www.biospace.com/news_story.aspx?StoryID=133072&amp;full=1</link><description>&lt;p&gt;DUBLIN, Ohio, March 31 /PRNewswire-FirstCall/ -- Cardinal Health today announced that its Clinical and Medical Products businesses that are expected to be spun off later this year as CareFusion Corporation, will reduce its global workforce by approximately 800 over six months and eliminate an additional 500 positions through normal attrition and not filling open roles.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;In addition...</description><pubDate>Tue, 31 Mar 2009 12:00:00 AM GMT</pubDate></item><item><title>World's First Proven Ultrasound Holographic Imaging Allows Correction of Nanoscale Subsurface Defects, Spurs Spin-off Company from SRC Work with Northwestern University  </title><link>http://www.biospace.com/news_story.aspx?StoryID=128634&amp;full=1</link><description> RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Just as x-ray technology, MRI and sonography transformed the practice of medicine, a newly created approach for seeing the invisible promises great potential for finding new ways to improve the health of human and microelectronic patients alike. Semiconductor Research Corporation (SRC), the worlds leading university-research consortium for semiconductors...</description><pubDate>Tue, 03 Mar 2009 12:00:00 AM GMT</pubDate></item><item><title>Small Bone Innovations, Inc. Announces Establishment of Small Bone Innovations Deutschland GmbH  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20090218005178&amp;newsLang=en</link><description>* Formation of Small Bone Innovations Deutschland GmbH increases SBis market presence in Germany, one of Europes largest SB&amp;J markets&lt;/p&gt;&lt;p&gt;* Addition to senior management team enhances SBis ability to realize the significant opportunity in international SB&amp;J markets&lt;/p&gt;&lt;p&gt;NEW YORK--(BUSINESS WIRE)--Small Bone Innovations, Inc., (SBi), a single-source provider of innovation, products, technology...</description><pubDate>Wed, 18 Feb 2009 12:00:00 AM GMT</pubDate></item><item><title>Cardinal Health, Inc. Unveils Spinoff Name  </title><link>http://www.bizjournals.com/columbus/stories/2009/02/16/daily1.html?</link><description>In devising a name for the division that Cardinal Health Inc. will spin off this year, the company turned to what its bringing together.  The Dublin health-care giant Monday said the name for its technology-centered clinical and medical products businesses will be CareFusion. The spinoff of the $4 billion-a-year business is expected to be completed by the end of June, when Cardinal Healths fiscal...</description><pubDate>Tue, 17 Feb 2009 12:00:00 AM GMT</pubDate></item><item><title>Bioheart, Inc. Announces Plans to Divest Non-Core Products to Increase Focus On Heart Failure Treatments  </title><link>http://www.globenewswire.com/newsroom/news.html?d=156464</link><description>SUNRISE, Fla., Dec. 16, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today that it is planning to spin out or sell off its interest in several non-core technology platforms in order to intensify its strategic focus on the treatment of patients suffering from heart failure. Bioheart holds the rights to multiple patents and patents pending related to these non-core technologies as...</description><pubDate>Tue, 16 Dec 2008 12:00:00 AM GMT</pubDate></item><item><title>Balan Biomedical Announces the Formation of  </title><link>http://www.biospace.com/news_story.aspx?StoryID=114490&amp;full=1</link><description>&lt;p&gt;Mr. Michael Pyszczek to lead broad-based team of battery experts.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;ROCHESTER, N.Y., Oct. 27 /PRNewswire/ -- Dr. Elisabeth Hager, Chairman and CEO of Balan Biomedical, Inc., announced the formation of the Balan Biomedical Battery Consulting Group. The newly created consulting group, reporting to Balan's Engineering Division, will be led by Mr. Michael Pyszczek, Balan's V.P. of...</description><pubDate>Mon, 27 Oct 2008 12:00:00 AM GMT</pubDate></item><item><title>Histogen, Inc. Establishes Histogen Aesthetics; New President Named  </title><link>http://www.biospace.com/news_story.aspx?StoryID=113642&amp;full=1</link><description>Dr. Lawrence A. Rheins Joins Histogen Aesthetics as President&lt;/p&gt;&lt;p&gt;SAN DIEGO/PHOENIX, October 20, 2008  Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn dermal fibroblasts, today announced the creation of Histogen Aesthetics LLC, a venture developing products for the growing medical aesthetic industries based on Histogens core technology...</description><pubDate>Tue, 21 Oct 2008 12:00:00 AM GMT</pubDate></item><item><title>Myriad Genetics, Inc. to Spin Off Drug Development Business from Its Molecular Diagnostics Business  </title><link>http://www.reuters.com/article/marketsNews/idINBNG39366820081020?rpc=44</link><description>SALT LAKE CITY, UT--(MARKET WIRE)--Oct 20, 2008 -- Myriad Genetics, Inc. (MYGN - News) (www.myriad.com), announced today that its Board of Directors has authorized management to proceed with preparations to spin off its research and drug development businesses from its molecular diagnostics business to form two well-capitalized, highly-focused, independent public companies.&lt;/p&gt;&lt;p&gt;The molecular...</description><pubDate>Tue, 21 Oct 2008 12:00:00 AM GMT</pubDate></item><item><title>Wake Forest University School of Medicine Spins Off Medical Device Firm, Applied Catheter Technologies  </title><link>http://www.bizjournals.com/triad/stories/2008/09/29/daily43.html?b=1222660800^1709985&amp;brthrs=1</link><description>Wake Forest University School of Medicine scientists have developed a new medical device technology and created a company to bring it to market  Applied Catheter Technologies.</description><pubDate>Fri, 03 Oct 2008 12:00:00 AM GMT</pubDate></item><item><title>Cardinal Health, Inc. to Spin Off 2 Segments (Clinical and Medical) as New, Global Medical-Technology Company; CEO Retires  </title><link>http://www.reuters.com/article/marketsNews/idINBNG16990520080929?rpc=44</link><description>DUBLIN, Ohio, Sept. 29 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced plans for a tax-free spin-off of its clinical and medical products businesses as a separate public company that will be led by current vice chairman and med-tech industry veteran David L. Schlotterbeck.&lt;/p&gt;&lt;p&gt;As a result...</description><pubDate>Mon, 29 Sep 2008 12:00:00 AM GMT</pubDate></item><item><title>DioGenix Spins Off from Parent Company  </title><link>http://www.biospace.com/news_story.aspx?StoryID=110635&amp;full=1</link><description>GAITHERSBURG, Md.--(BUSINESS WIRE)--DioGenix Inc. today announced its sale to Nerveda, Inc., a privately held specialty pharmaceutical and diagnostic company. As consideration for acquiring all of the outstanding stock of DioGenix, Ore Pharmaceuticals, Inc. (NASDAQ: ORXE - News), the former parent company of DioGenix, received an undisclosed amount of cash, as well as a small royalty on sales of a...</description><pubDate>Tue, 23 Sep 2008 12:00:00 AM GMT</pubDate></item><item><title>JMAR Technologies Forms Unit for Radiological/Nuclear Detection, Hires Leading Systems Engineer  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20080822005116&amp;newsLang=en</link><description>Companys New Spectral Labs Division, Led by James Winso, Fills Out JMAR Suite of Threat-Detection Technologies&lt;/p&gt;&lt;p&gt;SAN DIEGO--(BUSINESS WIRE)--JMAR Technologies, Inc. (OTCBB: JMAR) a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced that it has formed...</description><pubDate>Fri, 22 Aug 2008 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Smart Personalized Medicine, LLC&lt;/b&gt;, Founded by &lt;b&gt;Dr Richard Caruso&lt;/b&gt;, to Pursue Developing a New Breast Cancer Prognostic Test using Support Vector Machine (SVM) Technology from Health Discovery Corporation  </title><link>http://www.biospace.com/news_story.aspx?StoryID=107195&amp;full=1</link><description>HDC to Receive a Significant Equity Position in the New Company and Royalties Paid on a Per Test Basis from Breast Cancer Tests Performed&lt;/p&gt;&lt;p&gt;SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (HDC) (OTCBB: HDVY) today announced that Dr. Richard Caruso will change his role with the company from Board Member to Senior Advisor in order to activate a new independent company to be able...</description><pubDate>Mon, 18 Aug 2008 12:00:00 AM GMT</pubDate></item><item><title>Massachusetts Institute of Technology (MIT) Spinoff to Start Recruiting for 165 Jobs  </title><link>http://www.tampabay.com/news/business/article745043.ece</link><description>Job recruiting will start within weeks for a Massachusetts research and development firm that will build labs in Tampa and St. Petersburg to manufacture tiny biomedical machines.</description><pubDate>Wed, 30 Jul 2008 12:00:00 AM GMT</pubDate></item><item><title>Cellumen, Inc. Spins Off Personalized Medicine Unit as Cernostics Pathology, Inc.  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20080716006303&amp;newsLang=en</link><description>PITTSBURGH--(BUSINESS WIRE)--Cellumen, Inc., the Cellular Systems Biology Company (CSB), announced today that it has spun-out its personalized medicine unit, which will be called Cernostics Pathology, Inc. The objective of this new company is to become the leading provider of digital imaging pathology and tissue-based diagnostics products and services applied to personalized medicine. Cernostics Pathology...</description><pubDate>Thu, 17 Jul 2008 12:00:00 AM GMT</pubDate></item><item><title>PerkinElmer, Inc. Establishes ViaCord Research Institute??? to Further Cord Blood Stem Cell Advancements  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20080703005327&amp;newsLang=en</link><description>WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research Institute (VRI) aimed at investigating new potential future uses of umbilical cord blood-derived stem cells. Led by a team of leading scientists and physicians, VRI will focus on supporting science, technology and medical treatments using cord...</description><pubDate>Thu, 03 Jul 2008 12:00:00 AM GMT</pubDate></item><item><title>Apax Partners &amp; Co. Leads Spin-Out of Biomarker Discovery Company Sense Proteomic Limited; Sense Proteomic Limited Spun Out of Procognia Limited by Apax Partners &amp; Co. and its Management Team  </title><link>http://www.biospace.com/news_story.aspx?StoryID=99302&amp;full=1</link><description>&lt;p&gt;Maidenhead, UK: June 4, 2008, Sense Proteomic Ltd. today announced its spin out and its creation as a biomarker discovery company. It will now be focussing on using its proprietary protein array platform to discover novel panels of auto-antibody biomarkers in cancer and autoimmune diseases. Sense Proteomic was previously a subsidiary of the biosciences tools business Procognia Ltd, whose other...</description><pubDate>Wed, 04 Jun 2008 12:00:00 AM GMT</pubDate></item></channel></rss>